ROBERT A WOLFF to CD40 Antigens
This is a "connection" page, showing publications ROBERT A WOLFF has written about CD40 Antigens.
Connection Strength
0.184
-
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study. Lancet Oncol. 2021 01; 22(1):118-131.
Score: 0.184